PT Erritapharma (Indonesia)

Erritapharma is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Barat. The company was founded in 1973. Erritapharma was established by a group of visionary founders, including Dr. Ahmad Santoso and Dr. Rina Wijaya, who aimed to address the growing healthcare needs in Indonesia. The company has since evolved into a prominent player in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. The primary business line of Erritapharma is the production of generic drugs, while its secondary business line includes the development of over-the-counter (OTC) medications. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. Erritapharma's product portfolio includes a wide range of therapeutic categories, such as antibiotics, analgesics, and cardiovascular drugs. Some of its well-known product brands include EriCure, PainRelief, and CardioPlus. Internationally, Erritapharma has expanded its operations to several countries in Southeast Asia, including Malaysia, Thailand, and the Philippines, enhancing its global footprint. The company has also established strategic partnerships with international pharmaceutical firms to bolster its research and development capabilities. Erritapharma is a member of the Indonesian Pharmaceutical Association and actively participates in industry forums to stay abreast of the latest advancements in pharmaceutical technology. With a commitment to improving public health, Erritapharma's mission is to provide accessible and affordable healthcare solutions. The company envisions becoming a leading pharmaceutical company in Asia, driven by innovation and excellence in service.